Duke University Keeping an Eye on DTC Genomics Firms that Might be Infringing its APOE Patents

"We are always looking at entities, particularly DTC companies, who may be marketing APOE tests without a sublicense from Athena, are making misleading representations of those tests and their clinical interpretations, and are generally violating patent claims we own and have licensed, accordingly," said a Duke spokesperson.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.